Goriki Yuhei, Tanaka Atsushi, Nishihira Kensaku, Kawaguchi Atsushi, Natsuaki Masahiro, Watanabe Nozomi, Ashikaga Keiichi, Kuriyama Nehiro, Shibata Yoshisato, Node Koichi
Miyazaki Medical Association Hospital Cardiovascular Center, Miyazaki 880-0834, Japan.
Department of Cardiovascular Medicine, Saga University, Saga 849-8501, Japan.
J Clin Med. 2020 Mar 20;9(3):852. doi: 10.3390/jcm9030852.
In emergency clinical settings, it may be beneficial to use rapidly measured objective variables for the risk assessment for patient outcome. This study sought to develop an easy-to-measure and objective risk-score prediction model for in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI). A total of 1027 consecutive STEMI patients were recruited and divided into derivation ( = 669) and validation ( = 358) cohorts. A risk-score model was created based on the combination of blood test parameters obtained immediately after admission. In the derivation cohort, multivariate analysis showed that the following 5 variables were significantly associated with in-hospital death: estimated glomerular filtration rate <45 mL/min/1.73 m, platelet count <15 × 10/μL, albumin ≤3.5 g/dL, high-sensitivity troponin I >1.6 ng/mL, and blood sugar ≥200 mg/dL. The risk score was weighted for those variables according to their odds ratios. An incremental change in the scores was significantly associated with elevated in-hospital mortality ( < 0.001). Receiver operating characteristic curve analysis showed adequate discrimination between patients with and without in-hospital death (derivation cohort: area under the curve (AUC) 0.853; validation cohort: AUC 0.879), and there was no significant difference in the AUC values between the laboratory-based and Global Registry of Acute Coronary Events (GRACE) score ( = 0.721). Thus, our laboratory-based model might be helpful in objectively and accurately predicting in-hospital mortality in STEMI patients.
在急诊临床环境中,使用快速测量的客观变量进行患者预后风险评估可能是有益的。本研究旨在开发一种易于测量的客观风险评分预测模型,用于预测ST段抬高型心肌梗死(STEMI)患者的院内死亡率。共纳入1027例连续的STEMI患者,并分为推导队列(n = 669)和验证队列(n = 358)。基于入院后立即获得的血液检测参数组合创建了一个风险评分模型。在推导队列中,多变量分析显示以下5个变量与院内死亡显著相关:估计肾小球滤过率<45 mL/min/1.73 m²、血小板计数<15×10⁹/μL、白蛋白≤3.5 g/dL、高敏肌钙蛋白I>1.6 ng/mL和血糖≥200 mg/dL。根据这些变量的比值比对风险评分进行加权。评分的增量变化与院内死亡率升高显著相关(P<0.001)。受试者工作特征曲线分析显示,在有或无院内死亡的患者之间有足够的区分度(推导队列:曲线下面积(AUC)为0.853;验证队列:AUC为0.879),并且基于实验室的模型与全球急性冠状动脉事件注册(GRACE)评分的AUC值之间无显著差异(P = 0.721)。因此,我们基于实验室的模型可能有助于客观、准确地预测STEMI患者的院内死亡率。